Literature DB >> 16027187

Cloning and expression of bovine sodium/glucose cotransporter SGLT2.

F-Q Zhao1, T B McFadden, E H Wall, B Dong, Y-C Zheng.   

Abstract

The second member of the Na(+)/glucose cotransporter family, SGLT2, is a low-affinity active glucose transporter. In humans, it is predominantly located on the apical membrane of the S1 and S2 segments of renal proximal convoluted tubules, and, thus, may be mainly responsible for the reabsorption of D-glucose from the glomerular filtrate. By BLAST searching the GenBank database, we found expressed sequence tag sequences of SGLT2 in the cDNA library of bovine mammary tissues, indicating its expression in bovine mammary gland. To facilitate study of the mechanism of glucose reabsorption in bovine kidneys in maintenance of glucose homeostasis of lactating cows and the potential role of SGLT2 in the mammary gland, we cloned bovine SGLT2 and examined the distribution of its mRNA expression in bovine tissues. The full length mRNA of bSGLT2 is 2275 bp, and is predicted to encode a protein of 673 amino acids, with a molecular weight of approximately 73 kDa. The deduced amino acid sequence of bovine SGLT2 is 91, 90, 91, and 90% identical to human, rabbit, mouse, and rat SGLT2, respectively, and is 58 and 48% identical to bovine SGLT1 and SGLT5, respectively. The sequence of bSGLT2 contains several characteristically conserved sodium:solute symporter family signatures. Analysis of current bovine genomic data indicates that the bovine SGLT2 gene may consist of 14 exons. The major in vitro transcription and translation product of bovine SGLT2 cDNA migrated at an apparent molecular weight of 55 kDa. The SGLT2 mRNA was detected predominantly in bovine kidney as a 2.3-kb transcript, and at lower levels in all other bovine tissues examined, including the mammary gland, liver, lung, spleen, intestine, and skeletal muscle, as a 3.0-kb transcript. Expression of SGLT2 mRNA in bovine mammary gland increased more than 10-fold from late pregnancy to early lactation, similar to SGLT1. This indicates that SGLT2 may play a role in milk synthesis in the lactating mammary gland.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027187     DOI: 10.3168/jds.S0022-0302(05)72953-2

Source DB:  PubMed          Journal:  J Dairy Sci        ISSN: 0022-0302            Impact factor:   4.034


  6 in total

1.  Expression of mRNA for glucose transport proteins in jejunum, liver, kidney and skeletal muscle of pigs.

Authors:  J R Aschenbach; K Steglich; G Gäbel; K U Honscha
Journal:  J Physiol Biochem       Date:  2009-09       Impact factor: 4.158

2.  Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences.

Authors:  Ivan Sabolic; Ivana Vrhovac; Daniela Balen Eror; Maria Gerasimova; Michael Rose; Davorka Breljak; Marija Ljubojevic; Hrvoje Brzica; Anne Sebastiani; Serge C Thal; Christoph Sauvant; Helmut Kipp; Volker Vallon; Hermann Koepsell
Journal:  Am J Physiol Cell Physiol       Date:  2012-01-18       Impact factor: 4.249

3.  Functional properties and genomics of glucose transporters.

Authors:  Feng-Qi Zhao; Aileen F Keating
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

Review 4.  Biology of glucose transport in the mammary gland.

Authors:  Feng-Qi Zhao
Journal:  J Mammary Gland Biol Neoplasia       Date:  2013-11-13       Impact factor: 2.673

5.  Genetic ablation of SGLT2 function in mice impairs tissue mineral density but does not affect fracture resistance of bone.

Authors:  Kathryn M Thrailkill; R Clay Bunn; Sasidhar Uppuganti; Philip Ray; Kate Garrett; Iuliana Popescu; Jacquelyn S Pennings; John L Fowlkes; Jeffry S Nyman
Journal:  Bone       Date:  2020-01-25       Impact factor: 4.398

6.  Renal threshold for glucose reabsorption predicts diabetes improvement by sodium-glucose cotransporter 2 inhibitor therapy.

Authors:  Aya Osaki; Shuichi Okada; Tsugumichi Saito; Eijiro Yamada; Kumeo Ono; Yawara Niijima; Hiroto Hoshi; Masanobu Yamada
Journal:  J Diabetes Investig       Date:  2016-02-16       Impact factor: 4.232

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.